Journal
ACS CHEMICAL BIOLOGY
Volume 16, Issue 6, Pages 973-981Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acschembio.1c00006
Keywords
-
Categories
Funding
- National Health and Medical Research Council [APP1174941]
Ask authors/readers for more resources
The research demonstrates that glycosylation of CCL14 may influence its biological activity, especially with sialylated variants of CCL14(1-74) showing reduced activity when treated with plasmin.
Chemokines are secreted proteins that regulate leukocyte migration during inflammatory responses by signaling through chemokine receptors. Full length CC chemokine ligand 14, CCL14(1-74), is a weak agonist for the chemokine receptor CCR1, but its activity is substantially enhanced upon proteolytic cleavage to CCL14(9-74). CCL14 is O-glycosylated at Ser7, adjacent to the site of proteolytic activation. To determine whether glycosylation regulates the activity of CCL14, we used native chemical ligation to prepare four homogeneously glycosylated variants of CCL14(1-74). Each protein was assembled from three synthetic peptide fragments in one-pot using two sequential ligation reactions. We show that while glycosylation of CCL14(1-74) did not affect CCR1 binding affinity or potency of activation, sialylated variants of CCL14(1-74) exhibited reduced activity after treatment with plasmin compared to nonsialylated forms. These data indicate that glycosylation may influence the biological activity of CCL14 by regulating its conversion from the full-length to the truncated, activated form.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available